{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:52:08Z","timestamp":1778352728237,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[1997,12,16]],"date-time":"1997-12-16T00:00:00Z","timestamp":882230400000},"content-version":"vor","delay-in-days":168,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Parasitic diseases are closely related to the lack of sanitation (unavailability of potable water, inadequate disposal of human waste, lack of latrines) or the absence of personal hygiene. They are also closely linked to warm and humid climates, and are therefore considered tropical diseases. This chapter addresses chronic hookworm parasitosis and malaria, and their effect on women's health. Of all Helminthes, hookworms cause the most severe anemia because of iron deficiency due to chronic blood loss. Worldwide, an estimated 51% of pregnant women suffer from anemia \u2014 almost twice as many as non\u2010pregnant women. In severe cases (Hb &lt; 70 g\/l) the risk of perinatal maternal and child death increases up to 500\u2010fold. Anemia due to maternal deficiency affects the fetus, causes retarded intrauterine growth, and reduces fetal ability to absorb iron provided by the mother. Hookworms are nematodes that infect roughly 1 billion people. Their preferred habitat is the jejunum, where they attach to the mucous tissue to feed, and secrete an anticoagulant causing bleeding. Hookworm infections often begin in childhood. The worm enters the body through the skin and reaches the highest number at the end of adolescence and young adulthood. Little attention has been given to the treatment of pregnant women because of unavailability of safe antiparasitic drugs and fear of teratogenesis. However, there are new treatments, and the anthelminthic drugs may be administered in schools and organized women's groups in communities. During pregnancy anthelminthic treatment can improve maternal, fetal and infant health. Treatment given every 4 months has been shown to interrupt the transmission cycle of the parasite and help to improve the iron status of all women. Therapeutic strategies should be linked to other measures, such as promoting the use of shoes, introduction of potable water, education and treatment of the population at large, especially the school\u2010age population. An estimated 267 million people are annually infected by malaria, a parasitic disease caused by Protozoa of the genus <jats:italic>Plasmodium<\/jats:italic>. Malaria is transmitted by the Anopheles mosquito and is highly prevalent in tropical and subtropical regions located between 40 \u00b0 latitude North and 30 \u00b0 latitude South. It causes acute attacks that leave the human body in such a poor state that health problems resulting from these attacks become chronic. Due to the high mortality and morbidity associated with it, malaria is considered the most serious of tropical diseases and a major public\u2010health dilemma. Pregnant women are at high risk of becoming infected, as well as children in their first years of life. In pregnant women, malaria can cause anemia which can be the major cause of maternal mortality, especially during the first pregnancy. Malaria can also cause fetal anemia which frequently results in retarded intrauterine growth and low birth weight. Prophylactic treatment with antimalarial drugs during pregnancy is recommended in areas where the disease is endemic. The prophylactic treatment should focus primarily on primiparous women who are most susceptible. Chloroquine is safe and effective for antimalarial prophylaxis, and is not teratogenic. Proguanil is also safe for prophylactic use during pregnancy, particularly in areas where <jats:italic>P. falciparum<\/jats:italic> is resistant to chloroquine. Mefloquine may be used during the third trimester of pregnancy, only if other antimalarial drugs are unavailable or ineffective.<\/jats:p><\/jats:sec>","DOI":"10.1016\/s0020-7292(97)02865-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:09:59Z","timestamp":1027613399000},"page":"129-136","source":"Crossref","is-referenced-by-count":20,"title":["Effects of chronic parasitosis on women's health"],"prefix":"10.1002","volume":"58","author":[{"given":"R.","family":"Santiso","sequence":"first","affiliation":[]}],"member":"311","published-online":{"date-parts":[[1997,12,16]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Tropical Medicine and Parasitology","author":"Goldsmith R","year":"1989"},{"key":"e_1_2_1_3_2","volume-title":"Clinical Parasitology","author":"Chester PB","year":"1984"},{"key":"e_1_2_1_4_2","first-page":"131","volume-title":"Disease Control Priorities In Developing Countries","author":"Warren KS","year":"1993"},{"key":"e_1_2_1_5_2","volume-title":"Report of the African Regional Consultation on Control of Anemia in Pregnancy","author":"World Health Organization","year":"1989"},{"key":"e_1_2_1_6_2","article-title":"Primer Taller Subregional sobre el Control de las Anemias Nutricionales y la Deficiencia de Hierro","author":"Viteri FE","year":"1995","journal-title":"Guatemala: INCAP DCE\/017"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ajcn\/55.5.985","article-title":"Anaemia vs. iron deficiency: increased risk of preterm delivery in a prospective study","volume":"55","author":"School TO","year":"1992","journal-title":"Am J Nutr"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-2575-6_10"},{"key":"e_1_2_1_9_2","volume-title":"Nutrition and Metabolism in Pregnancy (Mother and Fetus)","author":"Rosso P","year":"1990"},{"key":"e_1_2_1_10_2","first-page":"109","article-title":"Pr\u00e9vention de l'an\u00e9mie ferriprive au cours de la grossesse par une supplementation martiale pr\u00e9coce: un essai control\u00e9","volume":"37","author":"De Benaze C","year":"1989","journal-title":"Rev Epidem Sant\u00e9 Publ"},{"issue":"1","key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0020-7292(95)02442-5","article-title":"The effect of chronic intestinal parasitic infection on maternal and perinatal outcome","volume":"52","author":"Weigel MM","year":"1996","journal-title":"Int J Gynecol Obstet"},{"key":"e_1_2_1_12_2","series-title":"WHO Technical Report Series No. 749","volume-title":"Report of a WHO Expert Committee","author":"World Health Organization","year":"1987"},{"key":"e_1_2_1_13_2","series-title":"Report of the Informal Consultation on Hookworm Infection and Anaemia in Girls and Women","author":"World Health Organization","year":"1994"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ajcn\/60.2.286","article-title":"Evaluation of effectiveness of iron folate supplementation and anthelmintic therapy against anemia in pregnancy: a study in the plantation sector of Sri Lanka","volume":"60","author":"Atukorala TM","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92246-P"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajcn\/57.2.135","article-title":"Low compliance with iron supplementation program, a study among pregnant women in Djakarta, Indonesia","volume":"57","author":"Schultink W","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_1_17_2","first-page":"A975","article-title":"Weekly iron supplementation is effective and safe in pregnant women","volume":"9","author":"Liu X\u2010N","year":"1995","journal-title":"(Abstract) Faseb J"},{"key":"e_1_2_1_18_2","first-page":"25","volume":"4","author":"World Health Organization","year":"1995","journal-title":"Weekly Epidemiological Records"},{"key":"e_1_2_1_19_2","unstructured":"World Health Organization.Tropical Diseases.1990 Geneva"},{"issue":"5","key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00034983.1994.11812894","article-title":"Malaria and anaemia in pregnant women in Urban Zanzibar, Tanzania","volume":"88","author":"Mateeli A","year":"1994","journal-title":"Ann Trop Med Par"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/02724936.1992.11747589"},{"issue":"6","key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4269\/ajtmh.1995.53.581","article-title":"Increase in birth weight following chloroquine chemoprophylaxis during the first pregnancy: results of a randomized trial in Cameroon","volume":"53","author":"Cut M","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_1_23_2","unstructured":"World Health Organization.WHO Model Prescribing Information Drugs Used in Parasitic Disease.1990 Geneva"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.3.595"},{"issue":"3","key":"e_1_2_1_25_2","first-page":"103","article-title":"Malaria chemosuppression in pregnancy. Its effects on the maternal malaria immunity","volume":"45","author":"Mutabingwa TK","year":"1993","journal-title":"Trop Geogr Med"},{"issue":"5","key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4269\/ajtmh.1994.51.515","article-title":"The efficacy of antimalarial regimens containing sulfadoxine\u2010pyrimethamine and\/or chloroquine in preventing peripheral and placental plasmodium falciparum infection among pregnant women in Malawi","volume":"51","author":"Schultz LJ","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90262-O"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(94)90135-X"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729297028658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729297028658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2FS0020-7292%2897%2902865-8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2FS0020-7292(97)02865-8","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/S0020-7292%2897%2902865-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:58:46Z","timestamp":1696352326000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1016\/S0020-7292%2897%2902865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1016\/S0020-7292(97)02865-8"],"URL":"https:\/\/doi.org\/10.1016\/s0020-7292(97)02865-8","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}